News related to
Range

MiniMax is preparing to price its Hong Kong initial public offering at the top of the marketed range, signalling strong demand for artificial intelligence developers as investors seek exposure to homegrown technology firms with global ambitions, according to people familiar with the transaction.

The Shanghai-based company, best known for its large language models and consumer-facing AI applications, has accelerated its listing timetable amid a surge in interest for Chinese technology firms that are perceived to be less exposed to US trade and regulatory pressures. Bankers involved in the deal say early indications from institutional investors point to robust demand, particularly from Asia-based funds focused on long-term technology themes.

MiniMax, founded in 2021 by former SenseTime and Megvii researchers, has positioned itself as one of the country’s leading independent AI model developers. Its core products include general-purpose foundation models, AI companions and enterprise solutions used across gaming, education and content creation. The firm competes with larger players backed by internet conglomerates while marketing itself as more agile and research-driven.

People familiar with the IPO said the company is targeting a valuation that reflects the premium currently attached to AI-related listings in Hong Kong. While final pricing has not yet been approved, the expectation is that the offer will be set at the upper end of the range to capitalise on strong order books built during early marketing. The shares are expected to begin trading later this year, subject to market conditions and regulatory clearances.

The decision to push for top-range pricing comes as Hong Kong’s equity market shows signs of renewed momentum after a prolonged slowdown. Technology and healthcare deals have drawn increasing attention, supported by policy measures aimed at reviving capital markets and encouraging listings by innovative firms. Fund managers say AI remains one of the few sectors where investors are willing to pay up for growth, despite broader concerns over economic headwinds.

MiniMax’s IPO is also being closely watched as a test case for how investors value Chinese AI companies that operate largely outside the orbit of the country’s major internet platforms. Unlike peers that rely heavily on parent companies for distribution and funding, MiniMax has raised capital from a mix of venture investors and strategic backers, allowing it to retain greater operational independence. That positioning has resonated with some institutional investors seeking exposure to AI innovation without heavy platform risk.

The company has continued to expand its research capabilities, investing heavily in computing infrastructure and talent. Industry analysts note that MiniMax has been among the more visible Chinese developers releasing multilingual models and consumer applications that aim to compete with global offerings. Its emphasis on overseas markets, including Southeast Asia and parts of the Middle East, has helped broaden its revenue base and narrative ahead of the listing.

Still, the firm faces stiff competition. Domestic rivals supported by large technology groups benefit from vast user ecosystems and deep pockets, while international players continue to dominate cutting-edge model development. Pricing the IPO aggressively could raise expectations around execution and financial performance at a time when monetisation of AI remains uneven across the industry.

Market participants say Hong Kong has become a more attractive venue for such listings as regulatory scrutiny on technology firms has stabilised compared with earlier years. The city’s exchange has also updated listing rules to better accommodate companies with heavy research spending and limited near-term profitability, a profile that fits many AI developers.

Bankers involved in the transaction say MiniMax has highlighted its progress in commercialising products, including enterprise contracts and consumer subscriptions, to address investor concerns around sustainability. While the company is not yet profitable, it has signalled a clearer path to revenue growth than at earlier funding rounds, helped by rising demand for customised AI solutions among businesses.

GLAS has carved out a niche as a specialist provider of services that support the lifecycle of debt instruments, from syndicated loans and direct lending to private credit and leveraged finance transactions. Founded in 2011 by Mia Drennan and Brian Carne, the firm oversees administration for a substantial portfolio of assets under management running into the hundreds of billions of dollars and employs over 450 staff across 16 offices worldwide. Drennan is expected to remain at the helm as chief executive, reflecting continuity in leadership amid the change in ownership.

The strategic rationale behind the investment reflects broader shifts in global credit markets. Demand for outsourced loan administration and trustee services has grown as lenders and borrowers navigate increasingly complex financing arrangements and regulatory requirements. Private credit, in particular, has expanded sharply, with non-bank lenders and institutional investors seeking specialist support for documentation, compliance and reporting functions that underpin large, bespoke transactions. GLAS’s suite of services has made it a go-to partner in this space, particularly for institutional clients negotiating intricate debt structures.

Financial terms of the deal disclosed by Oakley indicate its indirect contribution via Fund VI will be up to about £55 million, but wider valuations implied by market coverage suggest a total enterprise value near £1 billion. That figure aligns with expectations from advisers and reflects both GLAS’s established market position and the strategic value investors place on firms that facilitate the expanding private credit ecosystem. Oakley’s purchase follows a period of growth for GLAS under Levine Leichtman’s ownership, during which assets under administration reportedly rose from roughly $120 billion in 2021 to more than $750 billion today, driven by geographic expansion, technology investment and targeted acquisitions.

Oakley Capital’s profile has broadened in recent years as the firm has backed a variety of businesses across sectors including consumer brands, technology and business services. Its backing of GLAS reflects a deliberate push into specialised financial services where structural trends favour outsourced, technology-enhanced solutions. The involvement of La Caisse, a major institutional investor, underscores the appeal of GLAS’s business model to long-term capital allocators seeking exposure to the infrastructure of global credit markets.

Industry analysts have noted the appetite for loan agency services has been underpinned by the proliferation of private credit funds and a resurgence of syndicated lending activity following periods of market volatility. As banks and alternative lenders diversify their portfolios and jurisdictions tighten reporting standards, demand for independent administrators with global reach has grown. GLAS’s deep bench of expertise in handling complex transactions and its geographic footprint are seen as competitive advantages that could support accelerated growth under Oakley’s stewardship.

Executives from both sides have highlighted the strategic fit. Mia Drennan said the partnership with Oakley and La Caisse positions GLAS to expand its offerings and deepen client relationships, building on a track record of innovation in service delivery. Josh Kaufman, partner and head of Europe at Levine Leichtman, expressed pride in the firm’s role in GLAS’s development and confidence in its future trajectory under new ownership. Advisers on the transaction included Deutsche Bank and Robert W. Baird, working with GLAS and Levine Leichtman, reflecting the complexity and market interest in the deal.

Federal reforms regulating industrial hemp are reshaping the treatment landscape for sleep disorders, anxiety and epilepsy across the United Arab Emirates, as clinicians, researchers and regulators map how low-THC cannabis derivatives can be used safely within a tightly controlled system. The changes sit apart from the country’s framework on medical cannabis, which governs products with higher tetrahydrocannabinol content and remains subject to strict prescription and import rules.

The hemp law permits the cultivation, processing and use of cannabis varieties containing minimal THC, typically below 0.3 per cent, aligning the UAE with regulatory models adopted in several advanced economies. Officials say the objective is to unlock therapeutic and industrial value without opening pathways to recreational misuse. For patients, the most immediate implications are for cannabidiol-based preparations, which are non-intoxicating and increasingly studied for neurological and psychiatric conditions.

The policy shift creates new clinical options for people whose symptoms have proved resistant to conventional therapies. Insomnia and generalised anxiety disorder affect a growing share of the population, while epilepsy continues to pose treatment challenges for a subset of patients who do not respond adequately to standard anti-seizure medicines. Cannabidiol, or CBD, has drawn attention for its calming effects on the central nervous system and its role in reducing seizure frequency in certain epilepsy syndromes.

Specialists caution that hemp products are not a panacea. Evidence is strongest for specific childhood epilepsies, including Dravet and Lennox-Gastaut syndromes, where purified CBD has been shown to reduce seizure burden when added to existing regimens. Research into anxiety and sleep has produced more mixed findings, though small clinical trials and observational studies suggest benefits for sleep onset and stress modulation at carefully titrated doses.

Professor Barnes, a leading authority on cannabis medicine, notes that the global legal landscape has shifted rapidly. Medical cannabis containing higher THC levels is now legal in 71 countries under varying frameworks, reflecting broader acceptance of cannabinoid-based therapies when appropriately regulated. The UAE’s approach, by contrast, draws a bright line between hemp-derived products and medical cannabis, allowing limited therapeutic use while preserving the country’s zero-tolerance stance on recreational drugs.

Regulators emphasise that access will be medicalised rather than commercialised. Hemp-derived therapeutics are expected to move through pharmacy channels and clinical oversight, with product quality, labelling and traceability forming core pillars of compliance. Authorities have indicated that cultivation licences will be tightly issued, with genetics, THC thresholds and testing protocols specified to prevent diversion.

Healthcare providers see an opportunity to expand personalised care. Neurologists and psychiatrists report rising patient interest in non-sedating options that can be integrated with existing treatments. For epilepsy specialists, CBD’s favourable side-effect profile compared with some traditional anti-epileptic drugs is a significant draw, particularly for long-term management. Sleep physicians, meanwhile, are exploring whether hemp-derived formulations can reduce reliance on hypnotics that carry dependency risks.

Industry participants are preparing cautiously. Pharmaceutical distributors and research institutions are investing in clinical studies tailored to regional populations, recognising that dosage, formulation and delivery methods matter as much as legality. Oils, capsules and oral solutions are expected to dominate, given their dosing precision and lower risk profile compared with inhaled products.

Public health experts underline the need for clear guidance to avoid consumer confusion. Hemp products sold globally range from pharmaceutical-grade medicines to wellness supplements of uneven quality. The UAE framework seeks to close that gap by requiring evidence-based claims and physician involvement, reducing the risk of self-medication or exaggerated expectations.

The reforms also intersect with broader innovation goals. By enabling controlled research into cannabinoids, policymakers aim to position the country as a regional hub for life sciences, while maintaining strict ethical standards. Universities and hospitals are already collaborating on protocols to assess safety, efficacy and long-term outcomes in local cohorts.

Meteorologists said the pattern is being driven by an extension of a surface low-pressure system from the east, interacting with an upper-level trough. This combination is expected to create fluctuating conditions across coastal, inland and mountainous areas, with visibility reductions at times and heightened risks for motorists, mariners and aviation operators.

Early morning fog and mist are likely to form over internal and coastal regions, particularly during periods of high humidity and lighter winds overnight. Authorities warned that horizontal visibility could drop sharply in some areas, especially along highways linking major cities and in low-lying desert zones. Drivers have been urged to adhere to variable speed limits, use headlights appropriately and avoid sudden lane changes when fog is present.

As the day progresses, north-westerly winds are forecast to strengthen, occasionally reaching fresh to strong levels. These winds may raise dust and sand in exposed areas, further reducing visibility and contributing to degraded air quality for short periods. The strongest gusts are expected in open inland areas and near coastal stretches, where loose sand can be lifted rapidly.

Sea conditions are also expected to deteriorate at intervals. The Arabian Gulf is forecast to see moderate to rough seas at times, while conditions in the Sea of Oman may range from slight to moderate before becoming rough during peak wind periods. Small vessels, fishing boats and recreational watercraft have been advised to exercise caution, while port operators are monitoring conditions closely.

Temperatures are expected to remain seasonally mild overall, though noticeable fluctuations are likely. Daytime highs may dip slightly during unsettled phases, particularly in northern and eastern regions, while nights could feel cooler inland. Mountainous areas may experience lower temperatures and occasional cloud build-up, with a chance of light rainfall in isolated locations as moist air interacts with the upper trough.

Aviation authorities are factoring the conditions into flight planning, especially during early morning and late-night hours when fog is most likely. Delays or temporary diversions remain possible at airports if visibility falls below operational thresholds. Airlines have advised passengers to check flight status updates and allow additional time for travel to and from airports.

The weather pattern reflects a broader seasonal transition typical of early January, when shifts in pressure systems can lead to rapidly changing conditions across the region. Climatologists note that such periods often bring a mix of calm intervals and sudden gusty phases, requiring heightened situational awareness from the public.

Emergency services and municipal authorities have stepped up monitoring and preparedness measures. Variable message signs on major roads are being used to alert motorists to fog or reduced visibility, while marine warnings are being broadcast to coastal communities. Construction sites and outdoor work areas have been reminded to secure loose materials to prevent wind-related hazards.

Public health officials have advised people with respiratory conditions to limit prolonged outdoor exposure during dusty periods and to follow air-quality guidance when visibility is reduced by suspended particles. Schools and event organisers are also tracking updates to adjust outdoor activities if conditions worsen.

By Nitya Chakraborty In the neighbouring Bangladesh, the political developments take unpredictable course many times, but the latest alliance between the NCP, the party of the students body which led the July Revolution and the fundamentalist Jamaat-e-Islami, has shocked the progressive forces who supported the uprising that led to the fall of the Sheikh Hasina […]

The article Khaleda Zia’s Death Is Helping BNP In February 12 Polls Through Sympathy Wave appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).